Alignment Healthcare's CHRO Wagner Andreas P. Sells 12,032 Shares for $16.47 on 2023-08-25.
PorAinvest
lunes, 25 de agosto de 2025, 6:09 pm ET1 min de lectura
ALHC--
The shares were acquired as restricted stock units (RSUs) on February 7, 2025, and paid on that date. The filing also disclosed prior 10b5-1 plan sales by the same individual on June 11, 2025, totaling 19,399 shares for gross proceeds of $296,042.27. The filer attests that there is no undisclosed material adverse information [1].
The sale is part of a routine compliance process under Rule 144, indicating that the shares were acquired as part of the filer's compensation package. The presence of prior 10b5-1 activity suggests that the sales may be pre-planned and compliant with insider-trading rules. The filing does not indicate any immediate concerns from a corporate governance perspective, but investors should monitor for any patterns that could raise concerns [2].
References:
[1] https://www.stocktitan.net/sec-filings/ALHC/144-alignment-healthcare-inc-sec-filing-e44cb57b4b06.html
[2] Alignment Healthcare, Inc. Insider Sale Notice [Form 144]
Alignment Healthcare, Inc. (ALHC) has announced that Chief Human Resources Officer Wagner Andreas P. has recently sold 12,032 shares of the company's common stock at a price of $16.47 per share on August 25, 2025.
Alignment Healthcare, Inc. (ALHC) has recently announced that Chief Human Resources Officer Wagner Andreas P. has sold 12,032 shares of the company's common stock. The transaction, executed through Morgan Stanley Smith Barney LLC, took place on August 25, 2025, at a price of $16.47 per share, totaling an aggregate market value of $190,586.88 [1].The shares were acquired as restricted stock units (RSUs) on February 7, 2025, and paid on that date. The filing also disclosed prior 10b5-1 plan sales by the same individual on June 11, 2025, totaling 19,399 shares for gross proceeds of $296,042.27. The filer attests that there is no undisclosed material adverse information [1].
The sale is part of a routine compliance process under Rule 144, indicating that the shares were acquired as part of the filer's compensation package. The presence of prior 10b5-1 activity suggests that the sales may be pre-planned and compliant with insider-trading rules. The filing does not indicate any immediate concerns from a corporate governance perspective, but investors should monitor for any patterns that could raise concerns [2].
References:
[1] https://www.stocktitan.net/sec-filings/ALHC/144-alignment-healthcare-inc-sec-filing-e44cb57b4b06.html
[2] Alignment Healthcare, Inc. Insider Sale Notice [Form 144]

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios